Literature DB >> 8751864

Genetic and physical mapping of the Chediak-Higashi syndrome on chromosome 1q42-43.

F J Barrat1, L Auloge, E Pastural, R D Lagelouse, E Vilmer, A J Cant, J Weissenbach, D Le Paslier, A Fischer, G de Saint Basile.   

Abstract

The Chediak-Higashi syndrome (CHS) is a severe autosomal recessive condition, features of which are partial oculocutaneous albinism, increased susceptibility to infections, deficient natural killer cell activity, and the presence of large intracytoplasmic granulations in various cell types. Similar genetic disorders have been described in other species, including the beige mouse. On the basis of the hypothesis that the murine chromosome 13 region containing the beige locus was homologous to human chromosome 1, we have mapped the CHS locus to a 5-cM interval in chromosome segment 1q42.1-q42.2. The highest LOD score was obtained with the marker D1S235 (Zmax = 5.38; theta = 0). Haplo-type analysis enabled us to establish D1S2680 and D1S163, respectively, as the telomeric and the centromeric flanking markers. Multipoint linkage analysis confirms the localization of the CHS locus in this interval. Three YAC clones were found to cover the entire region in a conting established by YAC end-sequence characterization and sequence-tagged site mapping. The YAC contig contains all genetic markers that are nonrecombinant for the disease in the nine CHS families studied. This mapping confirms the previous hypothesis that the same gene defect causes CHS in human and beige pheno-type in mice and provides a genetic framework for the identification of candidate genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8751864      PMCID: PMC1914920     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  33 in total

1.  Organelle transport along microtubules - the role of KIFs.

Authors:  N Hirokawa
Journal:  Trends Cell Biol       Date:  1996-04       Impact factor: 20.808

Review 2.  The Chediak-Higashi syndrome and the homologous trait in animals.

Authors:  D B Windhorst; G Padgett
Journal:  J Invest Dermatol       Date:  1973-06       Impact factor: 8.551

3.  A comprehensive genetic map of the human genome based on 5,264 microsatellites.

Authors:  C Dib; S Fauré; C Fizames; D Samson; N Drouot; A Vignal; P Millasseau; S Marc; J Hazan; E Seboun; M Lathrop; G Gyapay; J Morissette; J Weissenbach
Journal:  Nature       Date:  1996-03-14       Impact factor: 49.962

Review 4.  Mechanisms of intracellular protein transport.

Authors:  J E Rothman
Journal:  Nature       Date:  1994-11-03       Impact factor: 49.962

5.  The Chediak-Higashi syndrome: a possible lysosomal disease.

Authors:  J G White
Journal:  Blood       Date:  1966-08       Impact factor: 22.113

6.  Human nidogen: cDNA cloning, cellular expression, and mapping of the gene to chromosome Iq43.

Authors:  D R Olsen; T Nagayoshi; M Fazio; M G Mattei; E Passage; D Weil; R Timpl; M L Chu; J Uitto
Journal:  Am J Hum Genet       Date:  1989-06       Impact factor: 11.025

7.  The murine gamma-chain of the T cell receptor is closely linked to a spermatocyte specific histone gene and the beige coat color locus on chromosome 13.

Authors:  F L Owen; B A Taylor; A Zweidler; J G Seidman
Journal:  J Immunol       Date:  1986-08-01       Impact factor: 5.422

8.  Defective granulocyte chemotaxis in the Chediak-Higashi syndrome.

Authors:  R A Clark; H R Kimball
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

9.  The "lazy" NK cells of Chediak-Higashi syndrome.

Authors:  S R Targan; R Oseas
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

10.  Chédiak-Higashi gene in humans I. Impairment of natural-killer function.

Authors:  T Haliotis; J Roder; M Klein; J Ortaldo; A S Fauci; R B Herberman
Journal:  J Exp Med       Date:  1980-05-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Neutrophil disorders and their management.

Authors:  R Lakshman; A Finn
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Linkage of combined factors V and VIII deficiency to chromosome 18q by homozygosity mapping.

Authors:  W C Nichols; U Seligsohn; A Zivelin; V H Terry; N D Arnold; D R Siemieniak; R J Kaufman; D Ginsburg
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 3.  Albinism: modern molecular diagnosis.

Authors:  S M Carden; R E Boissy; P J Schoettker; W V Good
Journal:  Br J Ophthalmol       Date:  1998-02       Impact factor: 4.638

4.  Genetic linkage of autosomal-dominant Alport syndrome with leukocyte inclusions and macrothrombocytopenia (Fechtner syndrome) to chromosome 22q11-13.

Authors:  A Toren; N Amariglio; G Rozenfeld-Granot; A J Simon; F Brok-Simoni; E Pras; G Rechavi
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

5.  Identification of mutations in two major mRNA isoforms of the Chediak-Higashi syndrome gene in human and mouse.

Authors:  M D Barbosa; F J Barrat; V T Tchernev; Q A Nguyen; V S Mishra; S D Colman; E Pastural; R Dufourcq-Lagelouse; A Fischer; R F Holcombe; M R Wallace; S J Brandt; G de Saint Basile; S F Kingsmore
Journal:  Hum Mol Genet       Date:  1997-07       Impact factor: 6.150

6.  A thiol proteinase inhibitor, E-64-d, corrects the abnormalities in concanavalin A cap formation and the lysosomal enzyme activity in leucocytes from patients with Chediak-Higashi syndrome by reversing the down-regulated protein kinase C activity.

Authors:  S H Cui; F Tanabe; H Terunuma; Y Iwatani; H Nunoi; K Agematsu; A Komiyama; A Nomura; T Hara; T Onodera; T Iwata; M Ito
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

7.  Chemoimmunotherapy for hemophagocytic lymphohistiocytosis: long-term results of the HLH-94 treatment protocol.

Authors:  Helena Trottestam; Annacarin Horne; Maurizio Aricò; R Maarten Egeler; Alexandra H Filipovich; Helmut Gadner; Shinsaku Imashuku; Stephan Ladisch; David Webb; Gritta Janka; Jan-Inge Henter
Journal:  Blood       Date:  2011-09-06       Impact factor: 22.113

Review 8.  Genetic defects in Chediak-Higashi syndrome and the beige mouse.

Authors:  R A Spritz
Journal:  J Clin Immunol       Date:  1998-03       Impact factor: 8.317

9.  Griscelli syndrome restricted to hypopigmentation results from a melanophilin defect (GS3) or a MYO5A F-exon deletion (GS1).

Authors:  Gaël Ménasché; Chen Hsuan Ho; Ozden Sanal; Jérôme Feldmann; Ilhan Tezcan; Fügen Ersoy; Anne Houdusse; Alain Fischer; Geneviève de Saint Basile
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

10.  Homozygosity and linkage-disequilibrium mapping of the syndrome of congenital hypoparathyroidism, growth and mental retardation, and dysmorphism to a 1-cM interval on chromosome 1q42-43.

Authors:  R Parvari; E Hershkovitz; A Kanis; R Gorodischer; S Shalitin; V C Sheffield; R Carmi
Journal:  Am J Hum Genet       Date:  1998-07       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.